Pain Therapeutics reported $19.92M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Acelrx Pharmaceuticals ACRX:US $ 14.14M 4.71M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Cara Therapeutics CARA:US $ 27.48M 5.23M
Eisai 4523:JP Y 176828M 34876M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Geron GERN:US $ 28.05M 749K
Johnson & Johnson JNJ:US $ 18.18B 616M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Novavax NVAX:US $ 668.88M 174.21M
Pain Therapeutics PTIE:US $ 19.92M 2.1M
Pfizer PFE:US $ 15640M 148M